Clinical Trials Directory

Trials / Completed

CompletedNCT07422415

Effects of E-Cigarette Use Among Young Egyptian Adults

Respiratory, Functional, and Radiological Effects of E-Cigarette Use Among Young 1 Egyptian Adults: A Cross-Sectional Study

Status
Completed
Phase
Study type
Observational
Enrollment
104 (actual)
Sponsor
Mansoura University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Electronic cigarettes (E-cigarettes) have gained significant popularity as an alternative to traditional combustible tobacco cigarette smoking. E-cigarettes are marketed as a safer alternative to conventional smoking forms. Many chronic smokers suppose that e-cigarettes are risk-free and can be used effectively as a smoking cessation tool. The market size of e-cigarette is increasing because of its rising popularity among the youth even though it is not an approved Food and Drug Administration (FDA) product yet

Detailed description

Most daily life activities as walking and household chores that affect quality of life are performed at a submaximal level of exertion. E-cigarettes may affect overall physical fitness and cardiovascular health. It is important to evaluate responses of all body systems interacting during exercise, including cardiovascular and pulmonary function, systemic circulation, peripheral circulation, blood, neuromuscular units, muscle metabolism, oxygen transport and utilization within skeletal muscles. The knowledge gap regarding the potential negative health effects of E-cigarettes is crucial, as e-cigarettes are newly prevailing smoking tools that are gaining rising popularity among the youth. Additionally, the false perception of the unregulated electronic cigarette smoking as a safe recreational habit may increase the prevalence among the population. The aim of this work is to assess the clinical and functional impact of E-cigarettes garette use in young Egyptian adults, and to evaluate the role of chest CT in follow-up of identified abnormalities.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTPulmonary Function testSpirometry was performed measure forced expiratiory volume at 1st second (FEV₁), forced vital capacity (FVC), and FEV₁/FVC ratio.

Timeline

Start date
2025-09-01
Primary completion
2025-12-31
Completion
2026-02-01
First posted
2026-02-20
Last updated
2026-02-20

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07422415. Inclusion in this directory is not an endorsement.